MYOS RENS Technology Inc (NASDAQ:MYOS)

1.25
Delayed Data
As of 3:30pm ET
 -0.05 / -3.85%
Today’s Change
0.74
Today|||52-Week Range
3.85
+3.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$15.8M

Company Description

MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.

Contact Information

MYOS RENS Technology, Inc.
45 Horsehill Road
Cedar Knolls New Jersey 07927
P:(973) 509-0444
Investor Relations:

Employees

Shareholders

Individual stakeholders49.18%
Other institutional3.10%
Mutual fund holders0.93%

Top Executives

Joseph ManelloCEO, Chief Financial & Accounting Officer
Joanne GoodfordManager-Facility Development & Head-Operations
Maghsoud DarianiHead-Science & Technology
Dante CarnevaleChief Strategist
Andrea LibrettiManager-National Sales